Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 10.4B | 9.0B | 8.4B |
Cost of revenue | 7.3B | 8.3B | 7.3B | 6.8B |
Gross profit | 1.6B | 2.1B | 1.8B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.2B | 1.5B | 1.2B | 1.2B |
Operating income | 276M | 464M | 369M | 246M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 17M | 201M | 7M | -9M |
Pretax income | 243M | 613M | 312M | 174M |
Tax provision | 52M | 112M | 67M | 32M |
Net income | 191M | 501M | 245M | 142M |
Basic EPS | 0.5 | 1.6 | 0.7 | 0.4 |
Diluted EPS | 0.5 | 1.6 | 0.7 | 0.4 |
Basic average shares | 300.3M | 304.6M | 306.3M | 306.7M |
Diluted average shares | 302.9M | 307.3M | 308.3M | 308.0M |
EBITDA | 453M | 511M | 548M | 407M |
Net income from continuing op. | 191M | 501M | 245M | 142M |
Minority interests | -28M | -14M | -20M | -12M |
Preferred stock dividends | — | — | — | — |